Lars Berglund

Title(s)Professor Emeritus, Endocrinology, Diabetes, and Metabolism
SchoolSchool of Medicine
AddressEducation Building
CA 95817
Phone916-703-9120
ORCID ORCID Icon0000000167051791 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Uppsala, SwedenM.D.1981Medicine
    University of Uppsala, SwedenPhD1977

    Collapse Overview 
    Collapse Overview
    Dr. Berglund is currently Interim Dean of the UC Davis School of Medicine. He is also Associate Vice Chancellor for Research at UC Davis, and has led the UC Davis School of Medicine research enterprise since 2008.

    Dr. Berglund served as the director of the UC Davis Clinical and Translational Science Center (CTSC) from its inception in 2006 until 2017, and has been very active in building an extensive collaborative framework. Previously he was the program director for the UC Davis GCRC, funded in 2004.

    Dr. Berglund has served as PI for several NIH R01 grants and has worked in the area of lipoprotein metabolism, vascular disease, and HIV for more than 20 years. He has published more than 200 peer-reviewed publications and reviews, most of which have resulted from mechanistic, patient-oriented studies.

    He is a member of the editorial boards of several journals, has chaired NIH and AHA study sections, and participated in several Endocrine Society guidelines committees as well as in the National Academies Steering Committee for the Decadal Survey on Biological and Physical Sciences in Space.

    Dr. Berglund served as an inaugural co-chair of the CTSA Consortium's Oversight Committee, and was closely involved in strategic planning.

    Collapse Research 
    Collapse Research Activities and Funding
    UC Davis Clinical and Translational Science Center
    NIH UL1TR001860Jul 1, 2016 - May 31, 2026
    Role: Co-Investigator
    Frontiers of University Training to Unlock the Research Enterprise (FUTURE)
    NIH DP7OD018426Sep 20, 2013 - Aug 31, 2018
    Role: Co-Investigator
    UC Davis Clinical and Translational Science Center
    NIH KL2TR000134Sep 30, 2006 - Sep 30, 2016
    Role: Principal Investigator
    UC Davis Clinical and Translational Science Center
    NIH TL1TR000133Sep 30, 2006 - Sep 30, 2016
    Role: Principal Investigator
    UC Davis Clinical and Translational Science Center
    NIH UL1TR000002Sep 30, 2006 - Sep 30, 2016
    Role: Principal Investigator
    UC Davis Clinical and Translational Science Center
    NIH KL2RR024144Sep 30, 2006 - Jun 30, 2016
    Role: Principal Investigator
    UC Davis Clinical and Translational Science Center
    NIH TL1RR024145Sep 30, 2006 - Jun 30, 2016
    Role: Principal Investigator
    UC Davis Clinical and Translational Science Center
    NIH UL1RR024146Sep 30, 2006 - Jun 30, 2016
    Role: Principal Investigator
    LIPOPROTEIN AND ADIPOSE TISSUE METABOLISM IN HIV
    NIH R01HL065938Jul 12, 2000 - Jun 30, 2007
    Role: Principal Investigator
    IMPLEMENTATION OF COMPREHENSIVE CLINICAL NUTRITION CURR
    NIH K07HL003938Apr 5, 2000 - Mar 31, 2005
    Role: Co-Investigator
    Regulation of Lipoprotein(a) Metabolism in Humans with Reference to Ethnicity
    NIH R01HL062705Feb 1, 2000 - Mar 31, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impaired incretin homeostasis in non-diabetic moderate-severe CKD. medRxiv. 2023 Dec 18. Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP, Roshanravan B. PMID: 38196612; PMCID: PMC10775324.
      View in: PubMed   Mentions:
    2. Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial. J Lipid Res. 2023 09; 64(9):100420. Law HG, Khan MA, Zhang W, Bang H, Rood J, Most M, Lefevre M, Berglund L, Enkhmaa B. PMID: 37482217; PMCID: PMC10445453.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Lipoprotein(a) and diet-a challenge for a role of saturated fat in cardiovascular disease risk reduction? Am J Clin Nutr. 2023 07; 118(1):23-26. Law HG, Meyers FJ, Berglund L, Enkhmaa B. PMID: 37178716; PMCID: PMC10447465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023 06; 374:107-120. Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky ML, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoglu LS, Catapano AL. PMID: 37188555.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    5. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022 10 14; 43(39):3925-3946. Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoglu LS, Catapano AL. PMID: 36036785; PMCID: PMC9639807.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    6. Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis. 2022 05; 349:53-62. Enkhmaa B, Berglund L. PMID: 35606076; PMCID: PMC9549811.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    7. Entrepreneurship and innovation in clinical and translational science. J Clin Transl Sci. 2022; 6(1):e15. Kimberly R, Berglund L. PMID: 35291216; PMCID: PMC8889222.
      View in: PubMed   Mentions: 1  
    8. Clinical and translational science and climate change: Time for action. J Clin Transl Sci. 2022; 6(1):e57. Solway J, Kenyon N, Berglund L. PMID: 35720971; PMCID: PMC9161039.
      View in: PubMed   Mentions: 2  
    9. Lp(a) and SARS-CoV-2: A conspiracy of two mysteries. J Intern Med. 2022 01; 291(1):8-10. Enkhmaa B, Berglund L. PMID: 34713951; PMCID: PMC8662052.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2022 01; 42(1):e48-e60. Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on . PMID: 34647487; PMCID: PMC9989949.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    11. Lp(a)-Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure. J Am Heart Assoc. 2021 09 07; 10(17):e020158. Berglund L, Kim K, Zhang W, Prakash N, Truax K, Anuurad E, Enkhmaa B. PMID: 34431330; PMCID: PMC8649226.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    12. Building an institutional K awardee program at UC Davis through utilization of CTSA resources. J Clin Transl Sci. 2021; 5(1):e171. Guo BP, Rainwater J, Neves S, Anuurad E, Wun T, Berglund L. PMID: 34733547; PMCID: PMC8532183.
      View in: PubMed   Mentions:
    13. The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials. J Nutr. 2020 08 01; 150(8):2089-2100. Kris-Etherton PM, Stewart PW, Ginsberg HN, Tracy RP, Lefevre M, Elmer PJ, Berglund L, Ershow AG, Pearson TA, Ramakrishnan R, Holleran SF, Dennis BH, Champagne CM, Karmally W, DELTA Investigators. PMID: 32492148; PMCID: PMC7398773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)? Nutrients. 2020 Jul 07; 12(7). Enkhmaa B, Petersen KS, Kris-Etherton PM, Berglund L. PMID: 32646066; PMCID: PMC7400957.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    15. PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability. J Endocr Soc. 2020 Jul 01; 4(7):bvaa073. Enkhmaa B, Kim K, Zhang W, Prakash N, Truax K, Anuurad E, Berglund L. PMID: 32685870; PMCID: PMC7358566.
      View in: PubMed   Mentions: 4  
    16. Stroke prevention: An uphill battle. Neurology. 2019 12 03; 93(23):987-988. Beckett LA, Berglund LF. PMID: 31672714.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 Sep 01; 104(9):3939-3985. Rosenzweig JL, Bakris GL, Berglund LF, Hivert MF, Horton ES, Kalyani RR, Murad MH, Vergès BL. PMID: 31365087.
      View in: PubMed   Mentions: 17     Fields:    
    18. Statins and Lp(a): The plot thickens. Atherosclerosis. 2019 10; 289:173-175. Enkhmaa B, Berglund L. PMID: 31443913; PMCID: PMC7098730.
      View in: PubMed   Mentions: 4     Fields:    
    19. Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families. J Lipid Res. 2019 09; 60(9):1603-1609. Enkhmaa B, Anuurad E, Zhang W, Kim K, Berglund L. PMID: 31324652; PMCID: PMC6718432.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans. J Clin Med. 2019 Jun 26; 8(7). Hieronimus B, Griffen SC, Keim NL, Bremer AA, Berglund L, Nakajima K, Havel PJ, Stanhope KL. PMID: 31247940; PMCID: PMC6678650.
      View in: PubMed   Mentions: 11  
    21. Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study. J Lipid Res. 2018 10; 59(10):1967-1976. Enkhmaa B, Anuurad E, Zhang W, Li CS, Kaplan R, Lazar J, Merenstein D, Karim R, Aouizerat B, Cohen M, Butler K, Pahwa S, Ofotokun I, Adimora AA, Golub E, Berglund L. PMID: 30012717; PMCID: PMC6168315.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages? Atherosclerosis. 2018 07; 274:230-231. Enkhmaa B, Prakash N, Berglund L. PMID: 29764695; PMCID: PMC7098672.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab. J Lipid Res. 2017 10; 58(10):2008-2016. Enkhmaa B, Anuurad E, Zhang W, Yue K, Li CS, Berglund L. PMID: 28798072; PMCID: PMC5625124.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    24. Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study. Arterioscler Thromb Vasc Biol. 2017 05; 37(5):997-1004. Enkhmaa B, Anuurad E, Zhang W, Li CS, Kaplan R, Lazar J, Merenstein D, Karim R, Aouizerat B, Cohen M, Butler K, Pahwa S, Ofotokun I, Adimora AA, Golub E, Berglund L. PMID: 28336560; PMCID: PMC5408307.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Lipid Lowering with Soluble Dietary Fiber. Curr Atheroscler Rep. 2016 Dec; 18(12):75. Surampudi P, Enkhmaa B, Anuurad E, Berglund L. PMID: 27807734.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimals
    26. The unresolved mystery of high-density lipoprotein: time for a paradigm shift? Transl Res. 2016 07; 173:1-6. Enkhmaa B, Anuurad E, Berglund L. PMID: 27037017.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res. 2016 07; 57(7):1111-25. Enkhmaa B, Anuurad E, Berglund L. PMID: 26637279; PMCID: PMC4918859.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    28. Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease. J Proteome Res. 2015 Dec 04; 14(12):5109-18. Krishnan S, Huang J, Lee H, Guerrero A, Berglund L, Anuurad E, Lebrilla CB, Zivkovic AM. PMID: 26535788.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    29. Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism. 2016 Apr; 65(4):381-90. Diffenderfer MR, Lamon-Fava S, Marcovina SM, Barrett PH, Lel J, Dolnikowski GG, Berglund L, Schaefer EJ. PMID: 26975530; PMCID: PMC4795479.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    30. Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016 Feb; 84(2):229-235. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Kaur P, Visla J, Karakas S, Berglund L. PMID: 26341109; PMCID: PMC4779071.
      View in: PubMed   Mentions: 2     Fields:    
    31. Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden. PLoS One. 2015; 10(3):e0121947. Erdembileg A, Mirsoian A, Enkhmaa B, Zhang W, Beckett LA, Murphy WJ, Berglund LF. PMID: 25815855; PMCID: PMC4376898.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    32. Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans. Atherosclerosis. 2015 Apr; 239(2):509-515. Enkhmaa B, Anuurad E, Zhang W, Kim K, Berglund L. PMID: 25710295; PMCID: PMC4361330.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms. J Med Primatol. 2015 Jun; 44(3):117-24. Enkhmaa B, Abbuthalha A, Anuurad E, Zhang W, Tarantal AF, Berglund L. PMID: 25683669; PMCID: PMC4430394.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    34. Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model? Transl Res. 2015 Jul; 166(1):41-3. Enkhmaa B, Anuurad E, Berglund L. PMID: 25701367; PMCID: PMC4978219.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    35. EngageUC: Developing an Efficient and Ethical Approach to Biobanking Research at the University of California. Clin Transl Sci. 2015 Aug; 8(4):362-6. Garrett SB, Koenig BA, Brown A, Hult JR, Boyd EA, Dry S, Dohan D, in collaboration with UC BRAID. PMID: 25581047; PMCID: PMC4499012.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Lipoprotein(a). . 2015 Jan 1; 25-55. Enkhmaa EB, Anuurad AE, Zhang ZW, Berglund BL. .
      View in: Publisher Site   Mentions:
    37. Sustained effects of a nurse coaching intervention via telehealth to improve health behavior change in diabetes. Telemed J E Health. 2014 Sep; 20(9):828-34. Young H, Miyamoto S, Ward D, Dharmar M, Tang-Feldman Y, Berglund L. PMID: 25061688; PMCID: PMC4148052.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    38. Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans. Atherosclerosis. 2014 Jul; 235(1):223-9. Enkhmaa B, Anuurad E, Zhang W, Berglund L. PMID: 24859635; PMCID: PMC4095745.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Obesity and lifespan health--importance of the fetal environment. Nutrients. 2014 Apr 24; 6(4):1725-36. Tarantal AF, Berglund L. PMID: 24763115; PMCID: PMC4011063.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    40. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis. Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28(3):423-37. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Stalenhoef A. PMID: 24840268; PMCID: PMC4028601.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    41. Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes. Obesity (Silver Spring). 2013 Dec; 21(12):2471-80. Rezvani R, Cianflone K, McGahan JP, Berglund L, Bremer AA, Keim NL, Griffen SC, Havel PJ, Stanhope KL. PMID: 23512943; PMCID: PMC3732502.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    42. Risk factors for cardiovascular disease: renewed interest in triglycerides. Clinical Lipidology and Metabolic Disorders. 2013 Feb 1; 8(1):1-4. Berglund BL, Sacks SF, Brunzell BJ. .
      View in: Publisher Site   Mentions:
    43. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol. 2013 Feb; 33(2):387-92. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L. PMID: 23202367; PMCID: PMC4537858.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    44. Patient information page from The Hormone Foundations. Patient guide to the assessment and treatment of hypertriglyceridemia (high triglycerides). J Clin Endocrinol Metab. 2012 Sep; 97(9):31A-32A. Berglund L, Brunzell J, Sacks FM. PMID: 22962678.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Sep; 97(9):2969-89. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF, Endocrine society. PMID: 22962670; PMCID: PMC3431581.
      View in: PubMed   Mentions: 265     Fields:    Translation:Humans
    46. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab (Lond). 2012 Jul 24; 9(1):68. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Keim NL, Havel PJ. PMID: 22828276; PMCID: PMC3463498.
      View in: PubMed   Mentions: 69  
    47. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. Atherosclerosis. 2012 Jul; 223(1):230-4. Gungor Z, Anuurad E, Enkhmaa B, Zhang W, Kim K, Berglund L. PMID: 22632920; PMCID: PMC3389284.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    48. The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis. BMC Endocr Disord. 2012 Mar 31; 12:2. Murad MH, Hazem A, Coto-Yglesias F, Dzyubak S, Gupta S, Bancos I, Lane MA, Erwin PJ, Berglund L, Elraiyah T, Montori VM. PMID: 22463676; PMCID: PMC3342117.
      View in: PubMed   Mentions: 25     Fields:    
    49. Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012 Apr; 5(2):121-9. CTSA Principal Investigators, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, Califf R, Stephens D, Mellman T, Verbalis J, Nadler L, Shekhar A, Ford D, Rizza R, Shaker R, Brady K, Murphy B, Cronstein B, Hochman J, Greenland P, Orwoll E, Sinoway L, Greenberg H, Jackson R, Coller B, Topol E, Guay-Woodford L, Runge M, Clark R, McClain D, Selker H, Lowery C, Dubinett S, Berglund L, Cooper D, Firestein G, Johnston SC, Solway J, Heubi J, Sokol R, Nelson D, Tobacman L, Rosenthal G, Aaronson L, Barohn R, Kern P, Sullivan J, Shanley T, Blazar B, Larson R, FitzGerald G, Reis S, Pearson T, Buchanan T, McPherson D, Brasier A, Toto R, Disis M, Drezner M, Bernard G, Clore J, Evanoff B, Imperato-McGinley J, Sherwin R, Pulley J. PMID: 22507116; PMCID: PMC3335735.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    50. The US Initiative: Clinical and Translational Science Awards – The UC Davis Perspective. . 2012 Jan 1; 3:18-28. Tarantal TA, Rainwater RJ, Wun WT, Berglund BL. .
      View in: Publisher Site   Mentions:
    51. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J Clin Nutr. 2012 Feb; 66(2):201-8. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Havel PJ, Keim NL. PMID: 21952692; PMCID: PMC3252467.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCellsCTClinical Trials
    52. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab. 2011 Dec; 96(12):E2034-8. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Keim NL, Havel PJ. PMID: 21956423; PMCID: PMC3232623.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    53. Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk. Metab Syndr Relat Disord. 2011 Dec; 9(6):411-8. Enkhmaa B, Anuurad E, Zhang W, Tran T, Berglund L. PMID: 21749171; PMCID: PMC3225061.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    54. Age as a modulator of inflammatory cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2011 Sep; 31(9):2151-6. Anuurad E, Enkhmaa B, Gungor Z, Zhang W, Tracy RP, Pearson TA, Kim K, Berglund L. PMID: 21700927; PMCID: PMC3158295.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    55. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr. 2011 Jul; 94(1):112-9. Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Berglund L, Keim NL, Havel PJ. PMID: 21613559; PMCID: PMC3127512.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    56. Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Transl Res. 2011 Aug; 158(2):92-8. Enkhmaa B, Anuurad E, Ozturk Z, Zhang W, Pearson TA, Berglund L. PMID: 21757153; PMCID: PMC3137802.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    57. Enigmatic role of lipoprotein(a) in cardiovascular disease. Clin Transl Sci. 2010 Dec; 3(6):327-32. Anuurad E, Enkhmaa B, Berglund L. PMID: 21167011; PMCID: PMC3075492.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    58. Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. Am J Cardiol. 2010 Nov 01; 106(9):1264-9. Enkhmaa B, Anuurad E, Zhang Z, Pearson TA, Berglund L. PMID: 21029822; PMCID: PMC2975905.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    59. HIV protease inhibitors and obesity. Curr Opin Endocrinol Diabetes Obes. 2010 Oct; 17(5):478-85. Anuurad E, Bremer A, Berglund L. PMID: 20717021; PMCID: PMC3076638.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    60. Integrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population. Metab Syndr Relat Disord. 2010 Dec; 8(6):531-8. Ozturk Z, Enkhmaa B, Shachter NS, Berglund L, Anuurad E. PMID: 20715976; PMCID: PMC3125560.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2010 Aug; 30(3):237-43. Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L. PMID: 20664256; PMCID: PMC3064933.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    62. Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population. Atherosclerosis. 2010 Aug; 211(2):526-30. Enkhmaa B, Anuurad E, Zhang W, Pearson TA, Berglund L. PMID: 20444451; PMCID: PMC2914160.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    63. Translational nutrition research at UC Davis--the key role of the Clinical and Translational Science Center. Ann N Y Acad Sci. 2010 Mar; 1190:179-83. Kasim-Karakas S, Hyson D, Halsted C, van Loan M, Chedin E, Berglund L. PMID: 20388150; PMCID: PMC4806777.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians. J Clin Endocrinol Metab. 2010 May; 95(5):2376-83. Anuurad E, Ozturk Z, Enkhmaa B, Pearson TA, Berglund L. PMID: 20194707; PMCID: PMC2869550.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    65. Linking scientific discovery and better health for the nation: the first three years of the NIH's Clinical and Translational Science Awards. Acad Med. 2010 Mar; 85(3):457-62. Califf RM, Berglund L, Principal Investigators of National Institutes of Health Clinical and Translational Science Awards. PMID: 20182118; PMCID: PMC4552187.
      View in: PubMed   Mentions: 33     Fields:    
    66. Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium. Acad Med. 2010 Mar; 85(3):463-9. Reis SE, Berglund L, Bernard GR, Califf RM, Fitzgerald GA, Johnson PC, National Clinical and Translational Science Awards Consortium. PMID: 20182119; PMCID: PMC2829722.
      View in: PubMed   Mentions: 37     Fields:    
    67. Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus. Curr Diab Rep. 2010 Feb; 10(1):61-9. Enkhmaa B, Ozturk Z, Anuurad E, Berglund L. PMID: 20425069; PMCID: PMC2821507.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    68. Postprandial metabolic responses to dietary glycemic index in hypercholesterolemic postmenopausal women. Prev Cardiol. 2010; 13(1):29-35. Bukkapatnam RN, Berglund L, Anuurad E, Devaraj S, Hyson D, Rafii F, Malmstein C, Villablanca AC. PMID: 20021624; PMCID: PMC3613123.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    69. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord. 2009 Oct; 7(5):401-10. Anuurad E, Semrad A, Berglund L. PMID: 19355810; PMCID: PMC3135885.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    70. Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy. Metab Syndr Relat Disord. 2009 Jun; 7(3):199-204. Lu G, Thomas-Geevarghese A, Anuurad E, Raghavan S, Minolfo R, Ormsby B, Karmally W, El-Sadr WM, Albu J, Berglund L. PMID: 19320559; PMCID: PMC3135887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Cardiovascular disease in women--challenges deserving a comprehensive translational approach. J Cardiovasc Transl Res. 2009 Sep; 2(3):251-5. Lee JS, Bertakis K, Meyers FJ, Chedin E, Tarantal A, Anderson K, Berglund L. PMID: 19655023; PMCID: PMC2719746.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    72. Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus. J Lipid Res. 2009 Sep; 50(9):1901-9. Reyes-Soffer G, Holleran S, Karmally W, Ngai CI, Chen NT, Torres M, Ramakrishnan R, Blaner WS, Berglund L, Ginsberg HN, Tuck C. PMID: 19429886; PMCID: PMC2724776.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    73. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009 May; 119(5):1322-34. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. PMID: 19381015; PMCID: PMC2673878.
      View in: PubMed   Mentions: 654     Fields:    Translation:Humans
    74. UC Davis CTSA: coming of age: integrated programs help put the spotlight on clinical and translational science. Clin Transl Sci. 2009 Apr; 2(2):98-101. Asmuth D, Wun T, Mullen N, Garcia E, Chedin E, Whitney E, Gillis M, Anderson K, Tarantal A, Kenyon N, Curry FR, Berglund L. PMID: 20443878; PMCID: PMC5350674.
      View in: PubMed   Mentions: 2     Fields:    
    75. ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans. J Lipid Res. 2009 Jul; 50(7):1472-8. Anuurad E, Yamasaki M, Shachter N, Pearson TA, Berglund L. PMID: 19252179; PMCID: PMC2694345.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    76. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients. J Intern Med. 2009 Jun; 265(6):708-16. Chmielewski M, Carrero JJ, Qureshi AR, Axelsson J, Heimbürger O, Berglund L, Bárány P, Rutkowski B, Lindholm B, Stenvinkel P. PMID: 19298498.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Strategies for innovation and interdisciplinary translational research: removal of barriers through the CTSA mechanism. J Investig Med. 2009 Feb; 57(2):474-6. Berglund L, Tarantal A. PMID: 19174699.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. Strategies for innovation and interdisciplinary translational research: research and career benefits and barriers. J Investig Med. 2009 Feb; 57(2):477-81. Benedyk M, Berglund L, Facciotti M, Mobley W, Zucker D. PMID: 19174698.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. Am J Cardiol. 2009 Feb 15; 103(4):523-7. Anuurad E, Tracy RP, Pearson TA, Beckett L, Berglund L. PMID: 19195514; PMCID: PMC3051347.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis. 2009 Jul; 205(1):290-5. Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L. PMID: 19135196; PMCID: PMC2700183.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    81. Role of lipoprotein(a) in cardiovascular disease current and future perspectives. J Am Coll Cardiol. 2008 Jul 08; 52(2):132-4. Berglund L, Anuurad E. PMID: 18598892.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    82. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta. 2008 Aug; 394(1-2):59-62. Kubala L, Lu G, Baldus S, Berglund L, Eiserich JP. PMID: 18440308; PMCID: PMC2474801.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. Atherosclerosis. 2008 Nov; 201(1):138-47. Rubin J, Kim HJ, Pearson TA, Holleran S, Berglund L, Ramakrishnan R. PMID: 18304554; PMCID: PMC2784197.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    84. Apolipoprotein E and cardiovascular diseases. Indian J Med Sci. 2008 Mar; 62(3):85-6. Anuurad E, Berglund L. PMID: 18376080.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    85. High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J Clin Endocrinol Metab. 2008 Apr; 93(4):1482-8. Anuurad E, Rubin J, Chiem A, Tracy RP, Pearson TA, Berglund L. PMID: 18252779; PMCID: PMC2291489.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    86. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007 Dec; 86(6):1611-20. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Dennis BH, Roheim PS, Ramakrishnan R, Reed R, Stewart K, Phillips KM, DELTA Investigators. PMID: 18065577.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    87. Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy. Atherosclerosis. 2008 May; 198(1):192-7. Anuurad E, Thomas-Geevarghese A, Devaraj S, Albu J, Minolfo R, El-Sadr WM, Lu G, Karmally W, Berglund L. PMID: 17996872; PMCID: PMC2362066.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    88. Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease. Am J Cardiol. 2007 Sep 01; 100(5):830-4. Anuurad E, Chiem A, Pearson TA, Berglund L. PMID: 17719328.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    89. Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. Transl Res. 2007 Jun; 149(6):317-23. Lu G, Chiem A, Anuurad E, Havel PJ, Pearson TA, Ormsby B, Berglund L. PMID: 17543850.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    90. HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk. Prev Cardiol. 2007; 10(2):96-103; quiz 104-5. Zou W, Berglund L. PMID: 17392622.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    91. ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study. J Lipid Res. 2007 Mar; 48(3):693-8. Anuurad E, Lu G, Rubin J, Pearson TA, Berglund L. PMID: 17172560.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    92. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med. 2006 Dec; 26(4):751-72. Anuurad E, Boffa MB, Koschinsky ML, Berglund L. PMID: 17110238.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    93. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res. 2006 Nov; 47(11):2475-81. Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R, Berglund L. PMID: 16888319.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    94. Lipoprotein metabolism: a well-tried tool to characterize dyslipidemic mechanisms. Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1201-3. Berglund L. PMID: 16709953.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation. 2006 Apr 18; 113(15):1871-8. Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szöcs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T. PMID: 16606792.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    96. Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]. J Lipid Res. 2006 May; 47(5):982-9. Rubin J, Kim HJ, Pearson TA, Holleran S, Ramakrishnan R, Berglund L. PMID: 16495513.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    97. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb. 2006; 35(3-4):314-21. Discepolo W, Wun T, Berglund L. PMID: 16877880.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    98. Adipose tissue, skeletal muscle, and insulin resistance across ethnicities--systems biology in action. Am J Clin Nutr. 2005 Dec; 82(6):1153-4. Berglund L. PMID: 16332645.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia. J Lipid Res. 2005 Dec; 46(12):2735-44. Myerson M, Ngai C, Jones J, Holleran S, Ramakrishnan R, Berglund L, Ginsberg HN. PMID: 16162940.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    100. Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Am J Clin Nutr. 2005 Jul; 82(1):146-54. Thomas-Geevarghese A, Raghavan S, Minolfo R, Holleran S, Ramakrishnan R, Ormsby B, Karmally W, Ginsberg HN, El-Sadr WM, Albu J, Berglund L. PMID: 16002813.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    101. The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children. Atherosclerosis. 2005 Apr; 179(2):387-93. Shachter NS, Rabinowitz D, Stohl S, Conde-Knape K, Cohn JS, Deckelbaum RJ, Berglund L, Shea S. PMID: 15777558.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    102. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol. 2004 Dec; 24(12):2219-26. Berglund L, Ramakrishnan R. PMID: 15345512; PMCID: PMC3275911.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimals
    103. High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort. J Am Coll Cardiol. 2004 May 19; 43(10):1828-33. Wu HD, Berglund L, Dimayuga C, Jones J, Sciacca RR, Di Tullio MR, Homma S. PMID: 15145108.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    104. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. Arterioscler Thromb Vasc Biol. 2004 Feb; 24(2):349-56. Lind S, Rudling M, Ericsson S, Olivecrona H, Eriksson M, Borgström B, Eggertsen G, Berglund L, Angelin B. PMID: 14656733.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    105. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep. 2003 Nov; 5(6):437-44. Hyson D, Rutledge JC, Berglund L. PMID: 14525676.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    106. Cholesterol absorption and the metabolic syndrome: a new look at an old area. Arterioscler Thromb Vasc Biol. 2003 Aug 01; 23(8):1314-6. Berglund L, Hyson D. PMID: 12909568.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    107. Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children. Obes Res. 2003 Jun; 11(6):709-21. Shea S, Aymong E, Zybert P, Berglund L, Shamoon H, Deckelbaum RJ, Basch CE. PMID: 12805392.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Therapy and clinical trials. Curr Opin Lipidol. 2003 Apr; 14(2):227-30. Jialal I, Berglund L. PMID: 12642792.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics. 2003 Feb; 111(2):332-8. Isasi CR, Deckelbaum RJ, Tracy RP, Starc TJ, Berglund L, Shea S. PMID: 12563060.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    110. Apolipoproteins and carotid artery atherosclerosis in an elderly multiethnic population: the Northern Manhattan stroke study. Atherosclerosis. 2002 Dec; 165(2):317-25. Jeng JS, Sacco RL, Kargman DE, Boden-Albala B, Paik MC, Jones J, Berglund L. PMID: 12417283.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    111. Postprandial lipemia and obesity--any unique features? Am J Clin Nutr. 2002 Aug; 76(2):299-300. Berglund L. PMID: 12144997.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. Nutr Metab Cardiovasc Dis. 2002 Aug; 12(4):163-72. Humphries SE, Berglund L, Isasi CR, Otvos JD, Kaluski D, Deckelbaum RJ, Shea S, Talmud PJ. PMID: 12514935.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    113. Lipoprotein (a): where does the atherogenicity reside? J Lab Clin Med. 2002 Mar; 139(3):131-2. Berglund L. PMID: 11944022.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Apolipoprotein E and diets: a case of gene-nutrient interaction? Curr Opin Lipidol. 2002 Feb; 13(1):25-32. Rubin J, Berglund L. PMID: 11790960.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    115. Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians. J Lipid Res. 2002 Feb; 43(2):234-44. Rubin J, Paultre F, Tuck CH, Holleran S, Reed RG, Pearson TA, Thomas CM, Ramakrishnan R, Berglund L. PMID: 11861665.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    116. Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City. Am J Cardiol. 2002 Jan 15; 89(2):178-83. Rodriguez C, Pablos-Méndez A, Palmas W, Lantigua R, Mayeux R, Berglund L. PMID: 11792339.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    117. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol. 2002 Jan; 22(1):141-6. Paultre F, Tuck CH, Boden-Albala B, Kargman DE, Todd E, Jones J, Paik MC, Sacco RL, Berglund L. PMID: 11788474; PMCID: PMC2812916.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    118. On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions. Biochim Biophys Acta. 2001 Dec 30; 1534(2-3):129-38. Freyschuss A, Al-Schurbaji A, Björkhem I, Babiker A, Diczfalusy U, Berglund L, Henriksson P. PMID: 11786299.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    119. Fluorescence-based, nonradioactive method for efficient detection of the pentanucleotide repeat (TTTTA)(n) polymorphism in the apolipoprotein(a) gene. Clin Chem. 2001 Oct; 47(10):1758-62. Rubin J, Pearson TA, Reed RG, Berglund L. PMID: 11568083.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    120. Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics. 2001 Sep; 108(3):E50. Talmud PJ, Berglund L, Hawe EM, Waterworth DM, Isasi CR, Deckelbaum RE, Starc T, Ginsberg HN, Humphries SE, Shea S. PMID: 11533368.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA. 2001 Jun 06; 285(21):2729-35. Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L. PMID: 11386928.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    122. Growth hormone and cardiovascular disease: an area in rapid growth. J Clin Endocrinol Metab. 2001 May; 86(5):1871-3. Thomas AM, Berglund L. PMID: 11344174.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    123. The APOE gene and diets--food (and drink) for thought. Am J Clin Nutr. 2001 Apr; 73(4):669-70. Berglund L. PMID: 11273839.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    124. Retinol binding protein as a surrogate measure for serum retinol: studies in vitamin A-deficient children from the Republic of the Marshall Islands. Am J Clin Nutr. 2001 Mar; 73(3):594-601. Gamble MV, Ramakrishnan R, Palafox NA, Briand K, Berglund L, Blaner WS. PMID: 11237937.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    125. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 2000 Dec; 20(12):2614-8. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, Berglund L, Tall AR. PMID: 11116061.
      View in: PubMed   Mentions: 166     Fields:    Translation:HumansCTClinical Trials
    126. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis. 2000 Dec; 36(6):1213-25. Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. PMID: 11096047.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    127. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol. 2000 Dec; 20(12):2619-24. Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L. PMID: 11116062.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    128. Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study. Am J Clin Nutr. 2000 Nov; 72(5):1119-27. Couch SC, Isasi CR, Karmally W, Blaner WS, Starc TJ, Kaluski D, Deckelbaum RJ, Ginsberg HN, Shea S, Berglund L. PMID: 11063438.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    129. Apolipoprotein epsilon2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University BioMarkers Study. Pediatrics. 2000 Sep; 106(3):568-75. Isasi CR, Shea S, Deckelbaum RJ, Couch SC, Starc TJ, Otvos JD, Berglund L. PMID: 10969104.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    130. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000 Sep; 20(9):2039-44. Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Ramasamy R, Berglund L, Ginsberg HN, Homma S, Cannon PJ. PMID: 10978246.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    131. Inverse association of physical fitness with plasma fibrinogen level in children: the Columbia University BioMarkers Study. Am J Epidemiol. 2000 Aug 01; 152(3):212-8. Isasi CR, Starc TJ, Tracy RP, Deckelbaum R, Berglund L, Shea S. PMID: 10933267.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    132. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab. 2000 Mar; 85(3):995-1000. Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA. PMID: 10720029.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    133. Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment on Lipids and Lipoproteins. Endotext. 2000. Enkhmaa B, Surampudi P, Anuurad E, Berglund L. View Publication.
    134. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res. 2000 Jan; 41(1):58-65. Sousa MM, Berglund L, Saraiva MJ. PMID: 10627502.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    135. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am J Clin Nutr. 1999 Dec; 70(6):992-1000. Berglund L, Oliver EH, Fontanez N, Holleran S, Matthews K, Roheim PS, Ginsberg HN, Ramakrishnan R, Lefevre M. PMID: 10584043.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    136. Relations of plasma fibrinogen level in children to measures of obesity, the (G-455-->A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: the Columbia University BioMarkers Study. Am J Epidemiol. 1999 Oct 01; 150(7):737-46. Shea S, Isasi CR, Couch S, Starc TJ, Tracy RP, Deckelbaum R, Talmud P, Berglund L, Humphries SE. PMID: 10512427.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    137. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology. 1999 Aug 11; 53(3):517-21. Romas SN, Tang MX, Berglund L, Mayeux R. PMID: 10449113.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    138. Erratum to “Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy trial (CARET)” [Atherosclerosis 143 (1999) 427–434]. Atherosclerosis. 1999 Aug 1; 145(2):423. Redlich RC, Chung CJ, Cullen CM, Blaner BW, Van Bennekum VA, Berglund BL. .
      View in: Publisher Site   Mentions:
    139. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET) Atherosclerosis. 1999 Aug; 145(2):425-32. Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Bennekum AM, Berglund L. PMID: 10488974.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    140. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA. 1999 Jul 21; 282(3):254-60. Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R. PMID: 10422994.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    141. Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man. Pharmacology. 1999 Jul; 59(1):51-6. Berglund L, Galbraith RA, Emtestam L, Drummond GS, Angelin B, Kappas A. PMID: 10352426.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    142. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999 May; 55(5):1899-911. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. PMID: 10231453.
      View in: PubMed   Mentions: 372     Fields:    Translation:Humans
    143. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET) Atherosclerosis. 1999 Apr; 143(2):427-34. Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Bennekum AM, Berglund L. PMID: 10217373.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    144. Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters. Eur J Clin Invest. 1999 Apr; 29(4):291-300. Werynski A, Nahorski Z, Berglund L, Ericsson S, Angelin B, Eriksson M. PMID: 10231341.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    145. Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels. J Lab Clin Med. 1999 Mar; 133(3):237-44. Barth JA, Deckelbaum RJ, Starc TJ, Shea S, Mosca L, Berglund L. PMID: 10072255.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res. 1999 Jan; 40(1):50-8. Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Holleran S, Tycko B, Leff T, Shachter NS. PMID: 9869649.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    147. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis. 1998 Aug; 139(2):391-9. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, Jones J, Boden-Albala B, Paik MC, Sacco RL. PMID: 9712347.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    148. A recurrent theme with a new spin: ACE polymorphism and cardiovascular disease. J Lab Clin Med. 1998 Jun; 131(6):485-6. Berglund L. PMID: 9626982.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    149. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int. 1998 May; 53(5):1336-42. Stenvinkel P, Heimbürger O, Tuck CH, Berglund L. PMID: 9573549.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    150. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach. J Lipid Res. 1998 Apr; 39(4):913-24. Berglund L, Witztum JL, Galeano NF, Khouw AS, Ginsberg HN, Ramakrishnan R. PMID: 9555954; PMCID: PMC3988111.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    151. Hepatic cholesterol metabolism in experimental nephrotic syndrome. Lipids. 1998 Feb; 33(2):165-9. al-Shurbaji A, Humble E, Rudling M, Lindenthal B, Berglund L. PMID: 9507238.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    152. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol. 1997 Dec; 17(12):3534-41. Pablos-Méndez A, Mayeux R, Ngai C, Shea S, Berglund L. PMID: 9437203.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    153. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS). Atherosclerosis. 1997 Nov; 135(1):109-18. Held C, Hjemdahl P, Rehnqvist N, Björkander I, Forslund L, Brodin U, Berglund L, Angelin B. PMID: 9395279.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    154. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997 Oct-Dec; 4(5-6):385-91. Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K. PMID: 9865671.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    155. The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects. J Intern Med. 1997 Oct; 242(4):329-37. Ericsson S, Berglund L, Frostegård J, Einarsson K, Angelin B. PMID: 9366812.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    156. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol. 1997 Sep; 17(9):1822-9. Tuck CH, Holleran S, Berglund L. PMID: 9327783.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    157. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J Clin Invest. 1997 Aug 15; 100(4):867-74. Pillarisetti S, Paka L, Obunike JC, Berglund L, Goldberg IJ. PMID: 9259586; PMCID: PMC508259.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    158. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis. Lipids. 1997 Aug; 32(8):847-52. al-Shurbaji A, Berglund L, Berge RK, Cederblad G, Humble E. PMID: 9270976.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    159. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke. 1997 May; 28(5):929-35. Sacco RL, Roberts JK, Boden-Albala B, Gu Q, Lin IF, Kargman DE, Berglund L, Hauser WA, Shea S, Paik MC. PMID: 9158627.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    160. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome. Eur J Clin Invest. 1997 Feb; 27(2):169-77. Stenvinkel P, Berglund L, Ericsson S, Alvestrand A, Angelin B, Eriksson M. PMID: 9061312.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    161. Status of lipids as a risk factor for stroke. Neuroepidemiology. 1997; 16(3):107-15. Gorelick PB, Schneck M, Berglund LF, Feinberg W, Goldstone J. PMID: 9159765.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    162. Plasma Lipoprotein(a) Is Related to Peritoneal Albumin Losses. Nephron. 1997 Jan 1; 76(2):241-241. Heimbürger HO, Stenvinkel SP, Berglund BL. .
      View in: Publisher Site   Mentions:
    163. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Nephrol Dial Transplant. 1997 Jan; 12(1):141-4. Eggertsen G, Heimbürger O, Stenvinkel P, Berglund L. PMID: 9027789.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    164. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males. J Clin Endocrinol Metab. 1996 Jul; 81(7):2633-7. Berglund L, Carlström K, Stege R, Gottlieb C, Eriksson M, Angelin B, Henriksson P. PMID: 8675589.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    165. Influence of a diet regimen on glucose homeostasis and serum lipid levels of male elite athletes. Metabolism. 1996 Apr; 45(4):435-41. Tegelman R, Aberg T, Eklöf R, Pousette A, Carlström K, Berglund L. PMID: 8609828.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    166. Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation. J Intern Med. 1996 Feb; 239(2):177-80. Jogestrand T, Fehrman-Ekholm I, Angelin B, Berglund L, Gäbel H. PMID: 8568487.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    167. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron. 1996; 72(2):135-44. Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B. PMID: 8684516.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    168. Lipoprotein(a) in chronic renal disease. Miner Electrolyte Metab. 1996; 22(1-3):16-21. Stenvinkel P, Berglund L. PMID: 8676811.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    169. Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol. 1995 Jul; 15(7):847-9. Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B. PMID: 7600115.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    170. Studies on lipoprotein metabolism in a family with jejunal chylomicron retention. Eur J Clin Invest. 1995 Apr; 25(4):271-80. Nemeth A, Myrdal U, Veress B, Rudling M, Berglund L, Angelin B. PMID: 7601203.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    171. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology. 1995 Apr; 21(4):1025-30. Ståhlberg D, Reihnér E, Rudling M, Berglund L, Einarsson K, Angelin B. PMID: 7705775.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    172. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids. Eur J Biochem. 1995 Feb 01; 227(3):715-22. Asiedu DK, al-Shurbaji A, Rustan AC, Björkhem I, Berglund L, Berge RK. PMID: 7867630.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    173. Diet and drug therapy for lipoprotein (a). Curr Opin Lipidol. 1995 Feb; 6(1):48-56. Berglund L. PMID: 7735716.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    174. Studies on rat liver phosphatidate phosphohydrolase and plasma lipids: effect of HMG-CoA reductase inhibitors. Biochim Biophys Acta. 1994 Aug 25; 1214(1):32-8. Humble E, al-Shurbaji A, Lund E, Berglund L. PMID: 8068726.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    175. Time-resolved fluorometry in the genetic diagnosis of familial defective apolipoprotein B-100. J Lipid Res. 1994 Aug; 35(8):1505-8. Eggertsen G, Eriksson M, Wiklund O, Iitiä A, Olofsson SO, Angelin B, Berglund L. PMID: 7989875.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    176. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia. Eur J Clin Invest. 1994 Jul; 24(7):488-98. Bröijersén A, Eriksson M, Larsson PT, Beck O, Berglund L, Angelin B, Hjemdahl P. PMID: 7957507.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    177. Altered apolipoprotein B metabolism in very low density lipoprotein from lovastatin-treated guinea pigs. J Lipid Res. 1994 Jun; 35(6):956-65. Berglund LF, Beltz WF, Elam RL, Witztum JL. PMID: 8077853.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    178. The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbits. J Clin Invest. 1994 Jun; 93(6):2732-7. Xiu RJ, Freyschuss A, Ying X, Berglund L, Henriksson P, Björkhem I. PMID: 8201011; PMCID: PMC294529.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    179. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin Nephrol. 1994 Apr; 41(4):183-90. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Björkhem I, Bergström J. PMID: 8026109.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    180. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett. 1994 Mar 14; 169(1-2):175-8. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, Eggertsen G, Berglund L, Angelin B, Linder J, Winblad B, et al. PMID: 8047277.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    181. [Analysis of apolipoproteins in clinical diagnosis. Standardization increases the diagnostic value]. Lakartidningen. 1994 Feb 23; 91(8):716-18, 723-4. Berglund L, Angelin B, Eggertsen G, Eriksson M, Henriksson P. PMID: 8189971.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Lipoprotein(a) in nephrotic syndrome. Kidney Int. 1993 Nov; 44(5):1116-23. Stenvinkel P, Berglund L, Heimbürger O, Pettersson E, Alvestrand A. PMID: 8264144.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    183. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis. Arterioscler Thromb. 1993 Nov; 13(11):1580-6. al-Shurbaji A, Skorve J, Berge RK, Rudling M, Björkhem I, Berglund L. PMID: 8218098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    184. Non-steady-state kinetics of low density lipoproteins in man: studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia. Eur J Clin Invest. 1993 Nov; 23(11):746-52. Eriksson M, Berglund L, Gabrielsson J, Lantz B, Angelin B. PMID: 8307094.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    185. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993 Oct; 39(10):2125-9. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. PMID: 8403397.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    186. Studies on triglyceride metabolism: phosphatidate phosphohydrolase from guinea pig harderian gland. Scand J Clin Lab Invest. 1993 Aug; 53(5):493-8. Humble E, Berglund L. PMID: 8210972.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    187. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats. J Lipid Res. 1993 Jul; 34(7):1177-85. Skorve J, al-Shurbaji A, Asiedu D, Björkhem I, Berglund L, Berge RK. PMID: 8371065.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    188. Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment. BMJ. 1993 Jun 26; 306(6894):1726-7. Olivecrona H, Ericsson S, Berglund L, Angelin B. PMID: 8343630; PMCID: PMC1678311.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    189. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 1993 Apr; 91(4):1282-8. Freyschuss A, Stiko-Rahm A, Swedenborg J, Henriksson P, Björkhem I, Berglund L, Nilsson J. PMID: 8473482; PMCID: PMC288096.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    190. Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. J Intern Med. 1993 Feb; 233(2):173-8. Berglund L, Wiklund O, Eggertsen G, Olofsson SO, Eriksson M, Lindén T, Bondjers G, Angelin B. PMID: 8433078.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    191. Photodynamic properties of Sn-protoporphyrin: clinical investigations and phototesting in human subjects. Acta Derm Venereol. 1993 Feb; 73(1):26-30. Emtestam L, Angelin B, Berglund L, Drummond GS, Kappas A. PMID: 8095746.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    192. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med. 1993 Jan; 94(1):13-20. Wiklund O, Angelin B, Bergman M, Berglund L, Bondjers G, Carlsson A, Lindén T, Miettinen T, Odman B, Olofsson SO, et al. PMID: 8420296.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    193. Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy. J Intern Med. 1992 Oct; 232(4):313-20. Ericsson S, Eriksson M, Berglund L, Angelin B. PMID: 1402634.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    194. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest. 1992 Apr; 89(4):1166-71. Henriksson P, Angelin B, Berglund L. PMID: 1532586; PMCID: PMC442975.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    195. Stimulation and inhibition of the activity of rat liver cytosolic phosphatidate phosphohydrolase by various phospholipids. J Lipid Res. 1991 Nov; 32(11):1869-72. Humble E, Berglund L. PMID: 1770306.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    196. Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor. Arterioscler Thromb. 1991 Jul-Aug; 11(4):827-37. Eriksson M, Angelin B, Henriksson P, Ericsson S, Vitols S, Berglund L. PMID: 2065036.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    197. Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. J Lipid Res. 1991 Jun; 32(6):935-40. Elmberger PG, Kalén A, Lund E, Reihnér E, Eriksson M, Berglund L, Angelin B, Dallner G. PMID: 1940625.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    198. Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids. Eur J Clin Invest. 1991 Jun; 21(3):344-9. Odman B, Ericsson S, Lindmark M, Berglund L, Angelin B. PMID: 1909637.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    199. Effect of n-3 fatty acids on the key enzymes involved in cholesterol and triglyceride turnover in rat liver. Lipids. 1991 May; 26(5):385-9. al-Shurbaji A, Larsson-Backström C, Berglund L, Eggertsen G, Björkhem I. PMID: 1895886.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    200. [Effect of pravastatin on hepatic cholesterol metabolism]. Fortschr Med. 1991 Mar 20; 109(8):189-94. Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B. PMID: 1905265.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    201. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest. 1991 Feb; 87(2):591-6. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. PMID: 1991842; PMCID: PMC296347.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    202. Influence of pravastatin on hepatic metabolism of cholesterol. N Engl J Med. 1991 Jan 10; 324(2):128. Hellerstein M. PMID: 1898532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    203. Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications. 1991 Jan-Mar; 5(1):18-22. Sjöberg S, Gjötterberg M, Berglund L, Möller E, Ostman J. PMID: 1830314.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    204. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb. 1991 Jan-Feb; 11(1):15-22. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P. PMID: 1987993.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    205. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. J Intern Med. 1990 Sep; 228(3):241-7. Wiklund O, Angelin B, Fager G, Eriksson M, Olofsson SO, Berglund L, Lindén T, Sjöberg A, Bondjers G. PMID: 2119417.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    206. Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis. Gut. 1990 Aug; 31(8):899-904. Berglund L, Angelin B, Hultcrantz R, Einarsson K, Emtestam L, Drummond G, Kappas A. PMID: 2387514; PMCID: PMC1378619.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    207. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990 Jul 26; 323(4):224-8. Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B. PMID: 2114543.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    208. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet. 1990 Jun 09; 335(8702):1360-3. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L, Bondjers G. PMID: 1971660.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    209. The effect of Acipimox on triacylglycerol metabolism in rat. Scand J Clin Lab Invest. 1990 Apr; 50(2):203-8. al-Shurbaji A, Berglund L, Björkhem I. PMID: 2339282.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    210. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. 1989 Nov 18; 2(8673):1178-80. Henriksson P, Eriksson M, Ericsson S, Rudling M, Stege R, Berglund L, Angelin B. PMID: 2572901.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    211. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med. 1989 Nov; 226(5):297-301. Ahnve S, Angelin B, Edhag O, Berglund L. PMID: 2809505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    212. Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism. J Lipid Res. 1989 Oct; 30(10):1591-600. Berglund L, Sharkey MF, Elam RL, Witztum JL. PMID: 2614261.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    213. [New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification]. Lakartidningen. 1989 Sep 27; 86(39):3249-50, 3255. Björkhem I, Berglund L. PMID: 2796509.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    214. Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest. 1989 Sep; 84(3):802-10. Eriksson M, Berglund L, Rudling M, Henriksson P, Angelin B. PMID: 2760213; PMCID: PMC329722.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    215. Rat adipose tissue phosphatidic acid phosphatase: lack of effect of nucleotides on cytosolic enzyme activity. Acta Chem Scand (Cph). 1989 Aug; 43(7):680-3. al-Shurbaji A, Berglund L. PMID: 2486133.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    216. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest. 1989 Aug; 19(4):395-403. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, Angelin B. PMID: 2550241.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    217. Tin-protoporphyrin and long wave length ultraviolet light in treatment of psoriasis. Lancet. 1989 Jun 03; 1(8649):1231-3. Emtestam L, Berglund L, Angelin B, Drummond GS, Kappas A. PMID: 2566782.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    218. Activation of rat liver cytosolic phosphatidic acid phosphatase by nucleoside diphosphates. Biochim Biophys Acta. 1989 Apr 26; 1002(3):382-7. Berglund L, Björkhem I, Angelin B, Einarsson K. PMID: 2540828.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    219. Treatment of psoriasis vulgaris with a synthetic metalloporphyrin and UVA light. Acta Derm Venereol Suppl (Stockh). 1989; 146:107-10. Emtestam L, Berglund L, Angelin B, Kappas A. PMID: 2609850.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    220. Lipid lowering in severe familial hypercholesterolaemia: efficacy and safety of a new regenerating system for selective apheresis of apolipoprotein B-containing lipoproteins. J Intern Med. 1989 Jan; 225(1):29-34. Eriksson M, Berg B, Berglund L, Lantz B, Angelin B. PMID: 2918270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    221. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects. Hepatology. 1988 May-Jun; 8(3):625-31. Berglund L, Angelin B, Blomstrand R, Drummond G, Kappas A. PMID: 3371880.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    222. Stimulatory effect of mevinolin on rat liver phosphatidic acid phosphatase. Biochim Biophys Acta. 1987 Jul 13; 920(1):20-5. Björkhem I, Berglund L. PMID: 3647797.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    223. Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy. Acta Med Scand. 1987; 221(3):317-20. Eriksson M, Lantz B, Berglund L, Angelin B. PMID: 3591471.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    224. Evidence against in vitro modulation of rat liver cholesterol 7 alpha-hydroxylase activity by phosphorylation-dephosphorylation: comparison with hydroxymethylglutaryl CoA reductase. Acta Chem Scand B. 1986 Jul; 40(6):457-61. Berglund L, Björkhem I, Angelin B, Einarsson K. PMID: 3766016.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    225. [Raw spiced fish as an indirect cause of severe anemia and weight loss]. Lakartidningen. 1986 Feb 12; 83(7):496. Berglund L, Angelin B. PMID: 3951280.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    226. A possible role of antithrombin III in venous thrombosis among alcoholics. Drug Alcohol Depend. 1982 Apr; 9(2):177-9. Wadstein J, Nilsson LH, Berglund L, Skude G. PMID: 7094840.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Apparent phosphorylation - dephosphorylation of soluble phosphatidic acid phosphatase in rat liver. Biochem Biophys Res Commun. 1982 Mar 15; 105(1):288-95. Berglund L, Björkhem I, Einarsson K. PMID: 6284148.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    228. Hormone-sensitive lipase of rat adipose tissue: correlation of activity with a protein of molecular weight 84 000. Biochim Biophys Acta. 1980 Aug 11; 619(2):440-4. Khoo JC, Berglund L, Jensen D, Steinberg D. PMID: 6250630.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    229. Resolution of hormone-sensitive triglyceride/diglyceride lipase from monoglyceride lipase of chicken adipose tissue. J Biol Chem. 1980 Jun 10; 255(11):5420-8. Berglund L, Khoo JC, Jensen D, Steinberg D. PMID: 6246107.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    230. Kinetic properties of pig pyruvate kinases type A from kidney and type M from muscle. Arch Biochem Biophys. 1979 Jul; 195(2):347-61. Berglund L, Humble E. PMID: 38749.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    231. Phosphorylation of rat kidney pyruvate kinase type L by cyclic 3',5'-AMP-dependent protein kinase. Biochim Biophys Acta. 1978 May 11; 524(1):68-77. Berglund L. PMID: 207341.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    232. Purification and characterization of pig kidney pyruvate kinase (type A). J Biol Chem. 1977 Sep 10; 252(17):6108-11. Berglund L, Ljungström O, Engström L. PMID: 893398.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    233. Studies on the cyclic 3':5'-AMP-stimulated pig liver protein kinase reaction with pyruvate kinase as substrate. J Biol Chem. 1977 Jan 25; 252(2):613-9. Berglund L, Ljungström O, Engström L. PMID: 13074.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    234. Studies on the kinetic effects of adenosine-3':5'-monophosphate-dependent phosphorylation of purified pig-liver pyruvate kinase type L. Eur J Biochem. 1976 Sep 15; 68(2):497-506. Ljunström O, Berglund L, Engström L. PMID: 10159.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    235. The minimum substrate of cyclic AMP-stimulated protein kinase, as studied by synthetic peptides representing the phosphorylatable site of pyruvate kinase (type L) of rat liver. Biochem Biophys Res Commun. 1976 Jun 07; 70(3):696-703. Zetterqvist O, Ragnarsson U, Humble E, Berglund L, Engström L. PMID: 180994.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    236. Non-dependence on native structure of pig liver pyruvate kinase when used as a substrate for cyclic 3',5'-AMP-stimulated protein kinase. Biochem Biophys Res Commun. 1975 Sep 16; 66(2):614-21. Humble E, Berglund L, Titanji V, Ljungström O, Edlund B, Zetterqvist O, Engström L. PMID: 170925.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    237. Cyclic 3',5'-AMP-stimulated and non-stimulated phosphorylation of protein fractions from rat-liver cell sap on incubation with (gamma-32P)ATP. Ups J Med Sci. 1974; 79(3):129-37. Ljungström O, Berglund L, Hjelmquist G, Humble E, Engström L. PMID: 4372760.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Lars's Networks
    Concepts (679)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (38)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California